UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.098

Sortiert nach

Navigating identity: Experiences of binary and non-binary transgender and gender non-conforming (TGNC) adults

International journal of transgender health, 2019-01, Vol.20 (2-3), p.181-194

2019

Volltextzugriff (PDF)

Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters

Journal of pain and symptom management, 2017-01, Vol.53 (1), p.85-95

2017

Volltextzugriff (PDF)

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

Breast cancer research and treatment, 2018-06, Vol.169 (2), p.391-396

2018

Volltextzugriff (PDF)

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer

International journal of breast cancer, 2018-01, Vol.2018, p.6729802-8

2018

Volltextzugriff (PDF)

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.506-506

2017

Volltextzugriff (PDF)

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

JAMA oncology, 2020-05, Vol.6 (5), p.676

2020

Volltextzugriff (PDF)

Clinician competencies: Strengths and limitations for work with transgender and gender non-conforming (TGNC) clients

International journal of transgender health, 2017-04, Vol.18 (2), p.154-171

2017

Volltextzugriff (PDF)

LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory

Human molecular genetics, 2015-03, Vol.24 (5), p.1336-1349

2015

Volltextzugriff (PDF)

HOW AGE-FRIENDLY UNIVERSITIES CAN COMBAT AGEISM

Innovation in aging, 2022-12, Vol.6 (Supplement_1), p.356-356

2022

Volltextzugriff (PDF)

Cryptic exon incorporation occurs in Alzheimer’s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43

Acta neuropathologica, 2017-06, Vol.133 (6), p.923-931

2017

Volltextzugriff (PDF)

Abstract PS2-07: Outcomes associated with disseminated tumor cells at surgery after neoadjuvant chemotherapy in high-risk early stage breast cancer: The I-SPY SURMOUNT study

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS2-07-PS2-07

2021

Volltextzugriff (PDF)

Abstract 3197: Adoptive T cell therapy using IL-7 and IL-15 expanded HER2-specific CD4 T cells for metastatic breast cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3197-3197

2023

Volltextzugriff (PDF)

Abstract PD1-10: Evaluation of SGN-LIV1a followed by AC in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD1-10-PD1-10

2021

Volltextzugriff (PDF)

Abstract P2-17-03: Real-world benefit of CDK4/6 inhibitor and endocrine therapy combination in metastatic breast cancer and correlation with neutropenia

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-17-03

2020

Volltextzugriff (PDF)

Abstract OT3-15-02: A randomized, double-blind, placebo-controlled study of 4-hydroxytamoxifen topical gel in women with mammographically dense breasts

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT3-15-02-OT3-15-02

2020

Volltextzugriff (PDF)

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice

Frontiers in cellular neuroscience, 2014-09, Vol.8, p.301-301

2014

Volltextzugriff (PDF)

OA15 - Clinical Outcomes of Breast Leptomeningeal Disease Treated with Intrathecal Trastuzumab, Intrathecal Chemotherapy, or Whole Brain Radiation Therapy

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E7-E7

2019

Volltextzugriff (PDF)

Clinical Outcomes of Breast Leptomeningeal Disease Treated with Intrathecal Trastuzumab, Intrathecal Chemotherapy, or Whole Brain Radiation Therapy

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E7

2019

Volltextzugriff (PDF)

Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1040-1040

2018

Volltextzugriff (PDF)

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4 + Th1 Responses and Potential Use as a Cancer Vaccine

Cancer immunology research, 2022-01, Vol.10 (1), p.108-125

2022

Volltextzugriff (PDF)

Abstract P2-20-02: Site of recurrence after neoadjuvant therapy: Clues to biology and impact on endpoints

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-20-02

2020

Volltextzugriff (PDF)

Abstract P3-09-02: Evaluation of a novel agent plus standard neoadjuvant therapy in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-09-02

2020

Volltextzugriff (PDF)

Abstract CT136: Evaluation of talazoparib in combination with irinotecan in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT136-CT136

2019

Volltextzugriff (PDF)

1 – 25 von 1.098

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.006)
Mit Volltextzugriff
(985)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(662)
Life Sciences & Biomedicine
(552)
Humans
(431)
Male
(251)
Female
(237)
Animals
(157)
Adult
(117)
Aged
(117)
Middle Aged
(111)
Biological And Medical Sciences
(102)
Mice
(90)
Oncology
(81)
Medical Sciences
(80)
Risk Factors
(68)
Physical Sciences
(65)
Science & Technology - Other Topics
(57)
Aged, 80 And Over
(56)
Cell Biology
(53)
Neurosciences & Neurology
(51)
Multidisciplinary Sciences
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gastroenterology
(32)
Cancer Research
(28)
Hepatology
(17)
Plos One
(16)
Journal Of The American Geriatrics Society
(12)
The Journal Of Urology
(12)
The New England Journal Of Medicine
(12)
Nature
(11)
Journal Of Clinical Oncology
(10)
Nature Genetics
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Navigating identity: Experiences of binary and non-binary transgender and gender non-conforming (TGNC) adults

Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters

DNAJC13 mutations in Parkinson disease

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

Clinician competencies: Strengths and limitations for work with transgender and gender non-conforming (TGNC) clients

LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory

HOW AGE-FRIENDLY UNIVERSITIES CAN COMBAT AGEISM

Cryptic exon incorporation occurs in Alzheimer’s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43

Abstract PS2-07: Outcomes associated with disseminated tumor cells at surgery after neoadjuvant chemotherapy in high-risk early stage breast cancer: The I-SPY SURMOUNT study

Abstract 3197: Adoptive T cell therapy using IL-7 and IL-15 expanded HER2-specific CD4 T cells for metastatic breast cancer

Abstract PD1-10: Evaluation of SGN-LIV1a followed by AC in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL

Abstract P2-17-03: Real-world benefit of CDK4/6 inhibitor and endocrine therapy combination in metastatic breast cancer and correlation with neutropenia

Abstract OT3-15-02: A randomized, double-blind, placebo-controlled study of 4-hydroxytamoxifen topical gel in women with mammographically dense breasts

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice

OA15 - Clinical Outcomes of Breast Leptomeningeal Disease Treated with Intrathecal Trastuzumab, Intrathecal Chemotherapy, or Whole Brain Radiation Therapy

Clinical Outcomes of Breast Leptomeningeal Disease Treated with Intrathecal Trastuzumab, Intrathecal Chemotherapy, or Whole Brain Radiation Therapy

Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009)

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4 + Th1 Responses and Potential Use as a Cancer Vaccine

Abstract P2-20-02: Site of recurrence after neoadjuvant therapy: Clues to biology and impact on endpoints

Abstract P3-09-02: Evaluation of a novel agent plus standard neoadjuvant therapy in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL

Abstract CT136: Evaluation of talazoparib in combination with irinotecan in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL

Suchergebnisse filtern